Sarcogenics
PrivateLast Round
Grant
Apr 23, 2025
Total Funding Raised
$749,220
Company Overview
Sarcogenics operates in Healthcare & Life Sciences and is based in Richmond, Virginia. Its latest recorded funding round was a Grant round in April 2025.
Sarcogenics is a biotechnology company developing a decellularized muscle matrix scaffold to regenerate muscle tissue for patients suffering from traumatic injuries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Defense Tech
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sarcogenics Comparables
Compare Sarcogenics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GenAssist, Inc. | 92% | |
| ECM Therapeutics, Inc. | 71% | |
| Cook Group Incorporated | 70% |
For institutional investors. Book with your work email.
Sarcogenics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 23, 2025 | ||||
| Grant | Oct 27, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sarcogenics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of War | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2025
Received $749K from the U.S. Department of War.
- Oct 27, 2022
Received grant funding.
For institutional investors. Book with your work email.
Sarcogenics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sarcogenics's valuation, stock price, and market status.
Is Sarcogenics a public or private company?
Sarcogenics is a private company.
What is the current stock price of Sarcogenics?
Sarcogenics is a private company, so its shares have no public market price. Caplight tracks Sarcogenics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sarcogenics worth (valuation)?
Valuation information for Sarcogenics is not publicly available.
Can I buy Sarcogenics stock?
Sarcogenics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sarcogenics's last funding round?
Sarcogenics's most recent funding round was Grant on April 23, 2025.
Who are the main investors in Sarcogenics?
Key investors in Sarcogenics include U.S. Department of War.
Will Sarcogenics IPO soon?
No public IPO plans have been announced for Sarcogenics.
How can I track Sarcogenics secondary market activity?
Caplight tracks bids, offers, and trades in Sarcogenics's shares on secondary markets.